AMINOCAPROIC ACID IN PLASTIC CONTAINER (aminocaproic acid)
AMINOCAPROIC ACID IN PLASTIC CONTAINER is indicated for the treatment of Fibrinolysis; Aplastic Anemia; Abruptio Placentae; Hepatic Cirrhosis; Prostate Cancer; Lung Cancer; Stomach Cancer; Cervical Cancer; Hematuria.
Details
- Status
- Prescription
- First Approved
- 1987-03-09
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
AMINOCAPROIC ACID IN PLASTIC CONTAINER Approval History
What AMINOCAPROIC ACID IN PLASTIC CONTAINER Treats
9 indicationsAMINOCAPROIC ACID IN PLASTIC CONTAINER is approved for 9 conditions since its original approval in 1987. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Fibrinolysis
- Aplastic Anemia
- Abruptio Placentae
- Hepatic Cirrhosis
- Prostate Cancer
- Lung Cancer
- Stomach Cancer
- Cervical Cancer
AMINOCAPROIC ACID IN PLASTIC CONTAINER Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in AMINOCAPROIC ACID IN PLASTIC CONTAINER's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications AMINOCAPROIC ACID IN PLASTIC CONTAINER treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to AMINOCAPROIC ACID IN PLASTIC CONTAINER
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT04814433 results posted | 20-01420 | Ph 4 | terminated | Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
AMINOCAPROIC ACID IN PLASTIC CONTAINER FDA Label Details
Indications & Usage
AMINOCAPROIC ACID IN PLASTIC CONTAINER is indicated for the treatment of Fibrinolysis; Aplastic Anemia; Abruptio Placentae; Hepatic Cirrhosis; Prostate Cancer; Lung Cancer; Stomach Cancer; Cervical Cancer; Hematuria.
Track AMINOCAPROIC ACID IN PLASTIC CONTAINER with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.